Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,918.50
(
-0.14%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.32
(
0.71%
)
Bitcoin
75,778.48
(
-0.15%
)
News Focus
News Focus
Post# of 405181
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

BonelessCat

Send PM Follow Ignore
Followers 258
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

BonelessCat

Re: sox040713 post# 163959

Tuesday, 11/15/2016 6:49:31 PM

Tuesday, November 15, 2016 6:49:31 PM

Post# of 405181

Dose optimizations are what P2 is for, which K is about to start. That's just the way it is.


Seems that can't be emphasized enough today as there seems to be a complete misunderstanding of trial phase purposes and the data required to include elements to move from purely safety (for example phase 1a focused entirely on toxicity in a multi-phase 1 trial set).

Bunny goes to Hawaii

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote